4/A//SEC Filing
Echo Therapeutics, Inc. 4/A
Accession 0001415889-16-005215
CIK 0001031927operating
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:38 PM ET
Size
5.8 KB
Accession
0001415889-16-005215
Insider Transaction Report
Form 4/AAmended
Edelman Elazer R
Director
Transactions
- Award
Options (Right to Buy)
2016-03-01+150,000→ 37,500 totalExercise: $1.12Exp: 2026-03-01→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]This Form 4A is to correct the vesting footnote which was originally incorrectly stated. The correct vesting is 25% of the options vest immediately and 25% vest each of April 1, 2016, July 1, 2016 and October 1, 2016.
- [F2]Granted pursuant to the Echo Therapeutics, Inc. 2008 Equity Compensation Plan.
Documents
Issuer
Echo Therapeutics, Inc.
CIK 0001031927
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001031927
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:38 PM ET
- Size
- 5.8 KB